Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety

• Status: Completed
• Trial end date: 2013-10-01
• Target enrollment: 0
• Participant gender: All

Summary

Phase III, multicentric, double blind, randomized study, controlled by Valeriana officinalis for evaluating the efficacy of association of Passiflora incarnata L; Crataegus Oxyacantha L and Salix alba L. on mild and moderate anxiety. The treatment period will last 6 weeks and be followed by a post treatment visit.

Hamilton anxiety scale will be used to assess anxiety.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Marjan Industria e Comercio ltda

Criteria

Inclusion Criteria:

• generalized anxiety disorder

• HAM-A scale < 17 and > 30

Exclusion Criteria:

• hypersensibility to any component

• patients with depression, schizophrenia ou suicidal ideas

• pregnant ou lactating

• heart, liver, lung or kidney important condition

• use of digitalis, AAS, anticoagulants agents, drugs with sedative or antidepressant action

• psychotherapy

• drug or alcohol dependence

• gastrointestinal ulcer history

• hyperthyroidism

• neoplasia

• coagulation disorders